In this online CME self-learning program:
Primary immunodeficiency disease (PID or PIDD) is a group of conditions encompassing more than 300 different genetic immune deficiencies. The heterogeneous etiology of PID leads to a vast array of clinical presentations, including infection, malignancy, autoimmunity, and inflammation.Once thought to be exceedingly rare, PID is increasingly being recognized as an underdiagnosed disease affecting approximately 6 million people worldwide – and about 1 in 1,200 people in the US.
Introduction content: cursory refresher and review of PID: Epidemiology & Classification [Objective 1]
Treatment Options for PID [Objective 2]
The following healthcare professionals: immunologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in immunology; and any other healthcare professionals with an interest in or who clinically encounter patients with PID.
This program is supported by an educational grant from Grifols.
Release Date: June 16, 2017 -- Expiration Date: June 16, 2019
Faculty: Asal Gharib, MD
By the end of the session the participant will be able to:
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Asal Gharib, M.D., University of California, Irvine Assistant Professor of Health Sciences Assistant Program Director Department of Immunology has no relevant conflicts of interest to disclose.
Disclosures of Educational Planners: Charles Turck, PharmD has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This program is supported by an educational grant from Grifols.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Treatment strategies in Gaucher disease
Alpha-1 antitrypsin deficiency (AATD): improving treatment and reducing barriers to care